Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
Year: 2014
Type: article
Study design: Observational Study
Abstract: AIM: Antipsychotics increase the risk of stroke. Their effect on myocardial infarction remains uncertain because people prescribed and not prescribed antipsychotic drugs differ in their underlying vascular risk making between-person comparisons difficult to interpret. The aim of our study was to investigate this association using the self-controlled case series design that eliminates between-person confounding effects. METHODS AND RESULTS: All the patients with a first recorded myocardial infarction and prescription for an antipsychotic identified in the Clinical Practice Research Datalink linked to the Myocardial Ischaemia National Audit Project were selected for the self-controlled case series. The incidence ratio of myocardial infarction during risk periods following the initiation of antipsychotic use relative to unexposed periods was estimated within individuals. A classical case-control study was undertaken for comparative purposes comparing antipsychotic exposure among cases and matched controls. We identified 1546 exposed cases for the self-controlled case series and found evidence of an association during the first 30 days after the first prescription of an antipsychotic, for first-generation agents [incidence rate ratio (IRR) 2.82, 95% confidence interval (CI) 2.0-3.99] and second-generation agents (IRR: 2.5, 95% CI: 1.18-5.32). Similar results were found for the case-control study for new users of first- (OR: 3.19, 95% CI: 1.9-5.37) and second-generation agents (OR: 2.55, 95% CI: 0.93-7.01) within 30 days of their myocardial infarction. CONCLUSION: We found an increased risk of myocardial infarction in the period following the initiation of antipsychotics that was not attributable to differences between people prescribed and not prescribed antipsychotics.
Source: European Heart Journal
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,756
Funders: Amgen, National Institute for Social Care and Health Research, Wellcome Trust, European Federation of Pharmaceutical Industries and Associations, Government of the United Kingdom, Cancer Research UK, National Institute for Health and Care Research, European Commission, Chief Scientist Office, Scottish Government Health and Social Care Directorate, Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council
Awards: G1877862647, Exploiting the potential offered by the increasing computerisation of health records for population based research., Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER), G3207356259, G3335867693, Improving the quality of care of patients with angina and heart attack, G393177772, G4457630332, NIHR Senior Investigator Award, Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium, Higher resolution cardiovascular epidemiology: unique insights from linking the national cardiac event register with primary care records and highly phenotyped cohorts., Software tools and online resources for the self-controlled case series method and its extensions, G5702163051, Administrative Data Research Centre, England (ADRCE)
OpenAlex ID: W2109184626
